Clinical Trials Directory

Trials / Unknown

UnknownNCT01314235

Influence of Clonidine on Thrombozytes of Blood of Patients Under Anticoagulation Therapy With ASS and Clopidogrel

The Influence of Clonidine on the Thrombozytes of Patients Under Double Anticagulation With ASS and Clopidogrel - an in Vitro Study

Status
Unknown
Phase
Study type
Observational
Enrollment
Sponsor
Goethe University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Clonidin works as a presynaptic agonist of alpha-sympathomimetic receptors of the brain but also in many other tissues. It is part of balanced anesthesia in general anesthesiology as well as a sedastive agent in intensive care units, but also serves as a third-line agent in many psychiatric diseases including ADHD, schizophrenia and PTSD. The investigators want to show whether clonidin has an procoagulatoric effect on thrombozytes of patients under double anticoagulaotirc treatment with ASS and clopidogrel. The investigators will use a flowcytometric assay to determine activation of thrombozytes when they come into contact with clonidine in vitro as well as Multiplate analyses to determine activation of thrombozytes, either thrombin.induced aggregation, ADP-induced aggregation or arachidonic acid-induced aggregation of thrombozytes.

Conditions

Timeline

Start date
2010-10-01
First posted
2011-03-14
Last updated
2011-03-14

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01314235. Inclusion in this directory is not an endorsement.